SUSAN JOHNSON: Open Payments
NPI 1831389147 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 17 payments from 9 companies in 2025. Trend: 2023 $529 · 2024 $889 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 5 | $136 |
| Novartis Pharmaceuticals Corporation | 5 | $121 |
| CVRx, Inc. | 1 | $99 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: Assure WCD, LEQVIO, Barostim Neo System, AMVUTTRA, Kerendia, FARXIGA, NEXLETOL, REPATHA.
Industry payments across FL — which companies pay providers there.
